185 related articles for article (PubMed ID: 37792025)
1. Comparison of parametric imaging and SUV imaging with [
Chen R; Ng YL; Yang X; Zhu Y; Li L; Zhao H; Zhou Y; Huang G; Liu J
Eur J Nucl Med Mol Imaging; 2024 Jan; 51(2):568-580. PubMed ID: 37792025
[TBL] [Abstract][Full Text] [Related]
2. Assessing dynamic metabolic heterogeneity in prostate cancer patients via total-body [
Chen R; Ng YL; Yang X; Zhu Y; Li L; Zhao H; Huang G; Liu J
Eur J Nucl Med Mol Imaging; 2024 Feb; 51(3):896-906. PubMed ID: 37889299
[TBL] [Abstract][Full Text] [Related]
3. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
4. Impact of uptake time on image quality of [
van der Sar ECA; Viol SLM; Braat AJAT; van Rooij R; Lam MGEH; de Jong HWAM; de Keizer B
Med Phys; 2023 Dec; 50(12):7619-7628. PubMed ID: 37093883
[TBL] [Abstract][Full Text] [Related]
5. Kinetic modeling and parametric imaging of
Yuan H; Zhang G; Sun T; Ren J; Zhang Q; Xiang Z; Liu E; Jiang L
Med Phys; 2024 Jan; 51(1):156-166. PubMed ID: 38043120
[TBL] [Abstract][Full Text] [Related]
6. Determination of optimal
Wen J; Zhu Y; Li L; Liu J; Chen Y; Chen R
Eur J Nucl Med Mol Imaging; 2022 May; 49(6):2086-2095. PubMed ID: 34962583
[TBL] [Abstract][Full Text] [Related]
7. First Total-Body Kinetic Modeling and Parametric Imaging of Dynamic
Chen R; Yang X; Ng YL; Yu X; Huo Y; Xiao X; Zhang C; Chen Y; Zheng C; Li L; Huang G; Zhou Y; Liu J
J Nucl Med; 2023 Jun; 64(6):960-967. PubMed ID: 36604180
[TBL] [Abstract][Full Text] [Related]
8. (68)Ga-PSMA-11 dynamic PET/CT imaging in biochemical relapse of prostate cancer.
Sachpekidis C; Eder M; Kopka K; Mier W; Hadaschik BA; Haberkorn U; Dimitrakopoulou-Strauss A
Eur J Nucl Med Mol Imaging; 2016 Jul; 43(7):1288-99. PubMed ID: 26753602
[TBL] [Abstract][Full Text] [Related]
9. Kinetic modeling of
Ringheim A; Campos Neto GC; Anazodo U; Cui L; da Cunha ML; Vitor T; Martins KM; Miranda ACC; de Barboza MF; Fuscaldi LL; Lemos GC; Colombo Junior JR; Baroni RH
EJNMMI Res; 2020 Feb; 10(1):12. PubMed ID: 32140850
[TBL] [Abstract][Full Text] [Related]
10. A prospective head-to-head comparison of [
Wang G; Li L; Zhu M; Zang J; Wang J; Wang R; Yan W; Zhu L; Kung HF; Zhu Z
Eur J Nucl Med Mol Imaging; 2023 Aug; 50(10):3126-3136. PubMed ID: 37233785
[TBL] [Abstract][Full Text] [Related]
11. Multiparametric dynamic whole-body PSMA PET/CT using [
Dias AH; Jochumsen MR; Zacho HD; Munk OL; Gormsen LC
EJNMMI Res; 2023 Apr; 13(1):31. PubMed ID: 37060394
[TBL] [Abstract][Full Text] [Related]
12. Total-body [
Wang Y; Chen Z; Zhu Y; Zhao H; Li L; Huang G; Xue W; Chen R; Liu J
Eur J Nucl Med Mol Imaging; 2023 Nov; 50(13):4096-4106. PubMed ID: 37578502
[TBL] [Abstract][Full Text] [Related]
13. 68Ga-PSMA-11 PET/CT derived quantitative volumetric tumor parameters for classification and evaluation of therapeutic response of bone metastases in prostate cancer patients.
Schmidkonz C; Cordes M; Goetz TI; Prante O; Kuwert T; Ritt P; Uder M; Wullich B; Goebell P; Bäuerle T
Ann Nucl Med; 2019 Oct; 33(10):766-775. PubMed ID: 31338731
[TBL] [Abstract][Full Text] [Related]
14. Hybrid imaging with [
Glemser PA; Rotkopf LT; Ziener CH; Beuthien-Baumann B; Weru V; Kopp-Schneider A; Schlemmer HP; Dimitrakopoulou-Strauss A; Sachpekidis C
Cancer Imaging; 2022 Sep; 22(1):53. PubMed ID: 36138437
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of early imaging with
Özülker F
Rev Esp Med Nucl Imagen Mol (Engl Ed); 2019; 38(2):100-105. PubMed ID: 30514659
[TBL] [Abstract][Full Text] [Related]
16. Biodistribution of [(68)Ga]PSMA-HBED-CC in Patients with Prostate Cancer: Characterization of Uptake in Normal Organs and Tumour Lesions.
Prasad V; Steffen IG; Diederichs G; Makowski MR; Wust P; Brenner W
Mol Imaging Biol; 2016 Jun; 18(3):428-36. PubMed ID: 27038316
[TBL] [Abstract][Full Text] [Related]
17. 68Ga-PSMA-11 Dynamic PET/CT Imaging in Primary Prostate Cancer.
Sachpekidis C; Kopka K; Eder M; Hadaschik BA; Freitag MT; Pan L; Haberkorn U; Dimitrakopoulou-Strauss A
Clin Nucl Med; 2016 Nov; 41(11):e473-e479. PubMed ID: 27607173
[TBL] [Abstract][Full Text] [Related]
18. Comparison of hybrid (68)Ga-PSMA PET/MRI and (68)Ga-PSMA PET/CT in the evaluation of lymph node and bone metastases of prostate cancer.
Freitag MT; Radtke JP; Hadaschik BA; Kopp-Schneider A; Eder M; Kopka K; Haberkorn U; Roethke M; Schlemmer HP; Afshar-Oromieh A
Eur J Nucl Med Mol Imaging; 2016 Jan; 43(1):70-83. PubMed ID: 26508290
[TBL] [Abstract][Full Text] [Related]
19. Optimal time-point for
Beheshti M; Paymani Z; Brilhante J; Geinitz H; Gehring D; Leopoldseder T; Wouters L; Pirich C; Loidl W; Langsteger W
Eur J Nucl Med Mol Imaging; 2018 Jul; 45(7):1188-1196. PubMed ID: 29476228
[TBL] [Abstract][Full Text] [Related]
20. Incremental Impact of [
Szigeti F; Schweighofer-Zwink G; Meissnitzer M; Hauser-Kronberger C; Hitzl W; Kunit T; Forstner R; Pirich C; Beheshti M
Mol Imaging Biol; 2022 Feb; 24(1):50-59. PubMed ID: 34519966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]